Gabriel T Schnickel

7PUBLICATIONS
76CO-AUTHORS
Transplantation immunologyMedical devicesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 05, 2025
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.

Beat Moeckli, Charles-Henri Wassmer, Sofia El Hajji

|Jul 11, 2023
Extended duration of machine perfusion: Maximizing organ utilization.

Aleah L Brubaker, Claire Bensard, Malcolm MacConmara

|Apr 07, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.

Benjamin V Tran, Dimitrios Moris, Daniela Markovic

|Jan 11, 2023
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium.

Elizabeth C Verna, Meaghan M Phipps, Karim J Halazun

|Jan 26, 2022
Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab.

Gabriel T Schnickel, Kassandra Fabbri, Mojgan Hosseini

|Jul 29, 2021
Successful heart and kidney transplantation from a deceased donor with PCR positive COVID-19.

Rachel Sigler, Mita Shah, Gabriel Schnickel

Pageof 2